The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
about
Further evidence for favorable cost-effectiveness of elderly influenza vaccinationVaccines for preventing influenza in the elderlyInfluenza vaccine for patients with chronic obstructive pulmonary diseasePneumococcal and influenza vaccination: current situation and future prospectsBTS Guidelines for the Management of Community Acquired Pneumonia in AdultsRates of influenza vaccination in older adults and factors associated with vaccine use: a secondary analysis of the Canadian Study of Health and AgingImpact of patient characteristics on the risk of influenza/ILI-related complicationsInfluenza vaccination in the elderly: why are the overall benefits still hotly debated?The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccinesChronic obstructive pulmonary diseaseIntradermal vaccination using the novel microneedle device MicronJet600: Past, present, and futureGuidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and preventionFactors associated with influenza vaccination coverage among the elderly in South Korea: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV)Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for biasNet Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.Cost-effective approaches to influenza prevention and treatment.Influenza A(H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients.Insights into the interaction between influenza virus and pneumococcusInfluenza infection and COPD.A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza virusesEnhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.Vaccination Against Seasonal or Pandemic Influenza in Emergency Medical Services.Factors contributing to suboptimal vaccination against influenza: results of a nationwide telephone survey of persons with cardiovascular disease.ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination.Rural Embedded Assistants for Community Health (REACH) network: first-person accounts in a community-university partnershipModels cannot predict future outbreaks: A/H1N1 virus, the paradigm.Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans.A surveillance system to reduce transmission of pandemic H1N1 (2009) influenza in a 2600-bed medical center.Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiologyCan Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions.Proteomics for biodefense applications: progress and opportunities.Comparing estimates of influenza-associated hospitalization and death among adults with congestive heart failure based on how influenza season is definedThreat-responsiveness and the decision to obtain free influenza vaccinations among the older adults in Taiwan.The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae.Healthcare maintenance in elderly patients with inflammatory bowel disease.Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers.Influenza mortality among the elderly in France, 1980-90: how many deaths may have been avoided through vaccination?Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in SpainCombining state administrative databases and provider records to assess the quality of care for children enrolled in Medicaid.Absence of influenza vaccination among high-risk older adults in Taiwan.
P2860
Q22305948-7FA8EDDC-3070-4D93-9756-496F4D260FEDQ24239997-8D5A9410-18EF-427B-8B0F-6CC31C4756A6Q24244657-94CA3C7A-31C4-48CD-94A5-F32C2714DD09Q24675532-92C2B3E2-3BA3-4897-B842-325D42B38A4BQ24675547-79ED6EAF-CAB1-4C69-9A12-8928992B1874Q24803408-2144C049-F6D7-4323-8C4C-4A039C2ADA02Q24805282-D50491B3-0A18-4727-A277-F142F8D8493BQ26770659-F0FF26E1-1DDE-4B8F-90D2-E7E41D92B44FQ27025076-F93EE432-6D73-40A9-B257-426744714513Q27027955-B7D70B33-6577-4A74-953A-649557175C31Q28087074-8F21B5E1-1059-41E9-8C31-A90D8D3D1E13Q28201389-474ED852-6C58-4A45-9F81-93116E85EE1CQ28365373-FB65C260-9011-44CD-9C91-7462FAC8583EQ28742116-FF0A19CD-3CF9-49B9-88DB-E7A12559C7DEQ30203021-3EC9D9FD-C87E-4AF6-99DC-5DA9C0CC57FDQ30233084-ACA87A39-14DD-44FF-988B-93CFF2C74F73Q30353204-B70C6FEA-0858-4269-ABD9-D67F9A32C042Q30355570-A6740D4C-0365-4652-8DD3-F5A9834F5CE8Q30366153-80AB598E-59AE-484C-9E4B-15820458A564Q30377217-5F04DBE9-E037-4F12-856F-C770469123F9Q30377295-A68BE43D-47D5-4BB8-8ED8-58BA9DAFBF38Q30384243-C52BE98B-01AE-4D53-A40F-332B80AA2106Q30384321-CD1A9027-5ED8-4CD3-8430-AC226F738C6EQ30388557-F2F53560-72EA-4912-A113-2D27C748AA42Q30392183-D11D503D-1EFA-490A-AC8D-9A3FD0CB44D5Q30397344-04532751-E1F9-4883-9A0F-50E5D3F5DD76Q30400174-81E50020-A757-44CA-858C-7B991BFB4F2FQ30414407-F090028A-37C8-42EB-8115-04DBD81E5FECQ30483582-ADFC2EF2-37ED-41E3-8F69-B55B08FFDF33Q31159585-A607E792-46A3-4705-AC45-9561C3ED9594Q33215043-C91E0F9D-3702-4BFF-9154-36996FD3E8ADQ33319642-BC03C9C0-9BDA-4AC7-B58B-EDC7BD1376C4Q33489052-5AEDDA83-F897-480F-A351-38ABEDF54A1AQ33554796-A4737C91-6D31-4412-A396-DEB4C8C56C09Q33621700-99AF593A-BD62-4271-A813-ABAC1EE17940Q33650384-7CD840B4-B7D9-4AAB-B095-A4DC058D7A15Q33703065-A0546520-A9B0-411A-A22A-0399C37E6D4BQ33704652-0E816EB2-55BB-4D5A-A24A-EB85833776D6Q33710689-99450248-4CB8-4851-B944-832509E67A52Q33717528-02098522-006C-4DF1-9591-1855945FF604
P2860
The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
The efficacy and cost effectiv ...... rsons living in the community.
@en
The efficacy and cost effectiv ...... rsons living in the community.
@nl
type
label
The efficacy and cost effectiv ...... rsons living in the community.
@en
The efficacy and cost effectiv ...... rsons living in the community.
@nl
prefLabel
The efficacy and cost effectiv ...... rsons living in the community.
@en
The efficacy and cost effectiv ...... rsons living in the community.
@nl
P2093
P1476
The efficacy and cost effectiv ...... rsons living in the community.
@en
P2093
Margolis KL
Von Sternberg T
Wuorenma J
P304
P356
10.1056/NEJM199409223311206
P407
P577
1994-09-01T00:00:00Z